Michael R. Verneris mostly deals with Immunology, Interleukin 21, Transplantation, Interleukin 12 and Lymphokine-activated killer cell. His studies deal with areas such as Stem cell and Degranulation as well as Immunology. The concepts of his Interleukin 21 study are interwoven with issues in Cytokine and Cell biology.
His Transplantation study is concerned with Internal medicine in general. His Internal medicine research incorporates elements of Gastroenterology, Transplantation Conditioning and Surgery. His Interleukin 12 research is multidisciplinary, incorporating elements of Natural killer T cell and Natural killer cell.
Michael R. Verneris spends much of his time researching Transplantation, Immunology, Internal medicine, Hematopoietic stem cell transplantation and Oncology. His Transplantation study incorporates themes from Hematopoietic cell, Umbilical cord, Leukemia and Human leukocyte antigen. His studies deal with areas such as Natural killer cell and Stem cell as well as Immunology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery. His research investigates the link between Hematopoietic stem cell transplantation and topics such as T cell that cross with problems in CD8. The various areas that Michael R. Verneris examines in his Interleukin 21 study include Natural killer T cell, Interleukin 12 and Cell biology.
Michael R. Verneris focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Immunology. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. His Transplantation research is multidisciplinary, relying on both Young adult, Hematopoietic cell, Umbilical cord and Cohort.
Michael R. Verneris works mostly in the field of Oncology, limiting it down to topics relating to B-cell acute lymphoblastic leukemia and, in certain cases, Relapsed refractory, as a part of the same area of interest. Michael R. Verneris combines subjects such as T cell, Human leukocyte antigen, Histocompatibility and Acute leukemia with his study of Hematopoietic stem cell transplantation. His research brings together the fields of Natural killer cell and Immunology.
Michael R. Verneris focuses on Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Young adult. He interconnects Hematopoietic cell, Umbilical cord, CD8 and Cohort in the investigation of issues within Transplantation. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Histocompatibility.
His study focuses on the intersection of Gastroenterology and fields such as Cord blood with connections in the field of Regimen. His Hematopoietic stem cell transplantation research includes elements of Myeloid, Hazard ratio, Confidence interval, Graft-versus-host disease and Leukemia. Michael R. Verneris has researched Survival analysis in several fields, including Chimeric Antigen Receptor T-Cell Therapy and Monoclonal.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude;Theodore W Laetsch;J. Buechner;S. Rives.
The New England Journal of Medicine (2018)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C natural killer cells with potent function
Bree Foley;Sarah Cooley;Michael R. Verneris;Michelle Pitt.
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood
Claudio G. Brunstein;Jonathan A. Gutman;Daniel J. Weisdorf;Ann E. Woolfrey.
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Michael R. Verneris;Mobin Karami;Mobin Karami;Jeanette Baker;Jeanette Baker;Anishka Jayaswal;Anishka Jayaswal.
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
Matthias Edinger;Yu An Cao;Michael R. Verneris;Michael H. Bachmann.
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
R Coleman Lindsley;Wael Saber;Brenton G Mar;Robert Redd.
The New England Journal of Medicine (2017)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee;Bree Foley;Todd R Lenvik;Yue Wang.
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
Jeffery S. Miller;Sarah Cooley;Peter Parham;Sherif S. Farag.
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
Michael R. Verneris;Claudio G. Brunstein;Juliet Barker;Margaret L. MacMillan.
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
Bree Foley;Sarah A Cooley;Michael R Verneris;Julie M Curtsinger.
Journal of Immunology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: